#obesity
India plans 50-metre junk food curbs around schools amid rise in obesity
Proposed rules could restrict sales of high-fat and high-sugar foods near India's 1.5 million schools, adding pressure on global food and beverage companies
India takes battle against junk food to shops near schools
India is proposing regulations to ban the sale of unhealthy food within 50 metres of schools. This initiative aims to reduce rising obesity rates among children, which has increased significantly in recent years. Multinational companies are likely to feel the…
What Ozempic is actually doing to obesity rates in the US
As GLP-1 medications continue to evolve and become more popular, they're having both a major moment and impact in the health landscape.
India new health challenge : Obesity and diabetes surge despite nutrition gains
Sharp rise in obesity , diabetes in five years since 2019 , shows latest health survey
Novo Nordisk’s next obesity battlefront: Winning beyond America
The weight loss pill had a strong U.S. launch this year, and Novo believes that will be replicated in other markets around the world.
From oncology to obesity, Pfizer bets big on India for its next growth wave
Pfizer is focusing on India for future growth. The company plans to launch new medicines quickly and at affordable prices. India is seen as a crucial market for new treatments in cancer, obesity, and vaccines. Pfizer is also working on local clinical studies …
India drugs regulator flags Eli Lilly obesity ads, campaign put on holdEli Lilly
Eli Lilly has paused its obesity awareness campaign in India after regulators warned it may violate drug advertising rules, raising compliance concerns.
Eli Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarity
Eli Lilly halted its obesity awareness campaign in India. The nation's drug regulator cautioned the company about potential violations. The campaign aimed to reframe obesity as a chronic disease. It featured various media without naming specific products. Lil…
Exclusive-Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarity
By Rishika Sadam HYDERABAD, May 12 (Reuters) - Eli Lilly paused its obesity awareness campaign in India after the nation's drugs regulator warned the company it could violate rules against advertising prescription medicines to consumers even indirectly...
Ozempic Market to Surpass USD 61.92 Billion by 2035 as GLP-1 Therapies Transform Diabetes and Obesity Care | SNS Insider
U.S. Ozempic Market to Witness Robust Growth, Reaching USD 23.94 Billion by 2035 with 11.45% CAGR U.S. Ozempic Market to Witness Robust Growth, Reaching USD 23.94 Billion by 2035 with 11.45% CAGR